164 related articles for article (PubMed ID: 1708571)
1. [Pattern analytic investigations of blast cells in myelodysplastic syndrome and secondary acute myeloid leukemia].
Baumann I; Harms H; Kuse R; Feller AC; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():135-8. PubMed ID: 1708571
[TBL] [Abstract][Full Text] [Related]
2. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies.
Orazi A; Cattoretti G; Heerema NA; Sozzi G; John K; Neiman RS
Mod Pathol; 1993 Sep; 6(5):521-5. PubMed ID: 8248107
[TBL] [Abstract][Full Text] [Related]
3. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.
Kitagawa M; Yoshida S; Kuwata T; Tanizawa T; Kamiyama R
Am J Pathol; 1994 Aug; 145(2):338-44. PubMed ID: 8053492
[TBL] [Abstract][Full Text] [Related]
4. In vitro growth modulation by L-ascorbic acid of colony-forming cells from bone marrow of patients with myelodysplastic syndromes.
Park CH; Kimler BF; Bodensteiner D; Lynch SR; Hassanein RS
Cancer Res; 1992 Aug; 52(16):4458-66. PubMed ID: 1643638
[TBL] [Abstract][Full Text] [Related]
5. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
Greenberg PL
Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
[No Abstract] [Full Text] [Related]
6. [Myelodysplastic syndrome: a review].
Creutzig U; Hoelzer D
Klin Padiatr; 1987; 199(3):169-72. PubMed ID: 3626418
[TBL] [Abstract][Full Text] [Related]
7. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
8. Expression of myeloid differentiation antigens on myeloblasts in bone marrow of patients with myelodysplastic syndromes.
Borbenyi Z; Ghosh A; Cinkotai K; Balogh E; Moore M
Biomed Pharmacother; 1987; 41(2):101-4. PubMed ID: 3475134
[TBL] [Abstract][Full Text] [Related]
9. The expression of the ras p21 oncoprotein in the bone marrow smears of children with acute leukemia.
Kalmanti M; Kalmantis T; Vassilaki M; Galanopoulos A; Grenzelias D; Spandidos DA
Anticancer Res; 1992; 12(6B):2177-80. PubMed ID: 1295465
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous expression of lymphoid and myeloid phenotypes in acute leukemia arising from myelodysplastic syndrome.
Komatsu N; Yoshida M; Eguchi M; Akashi M; Sasaki R; Sakamoto S; Miura Y
Am J Hematol; 1988 Jun; 28(2):103-6. PubMed ID: 3164979
[TBL] [Abstract][Full Text] [Related]
11. In vitro suspension culture reactions to 1,25 dihydroxyvitamin D3 in relation to bone marrow morphology and prognosis in patients with myelodysplastic syndromes.
Hellström-Lindberg E; Robèrt KH; Ahnsén B; Elmhorn-Rosenborg A; Kock Y; Ost A
Leuk Res; 1992; 16(5):529-35. PubMed ID: 1625479
[TBL] [Abstract][Full Text] [Related]
12. Cell-cycle progression rates and sister chromatid exchange frequencies in the bone marrow of patients with myelodysplastic syndrome and acute myeloid leukemia.
Jones BM; White AD; Culligan DJ; Jacobs A
Cancer Genet Cytogenet; 1992 Aug; 62(1):66-9. PubMed ID: 1521237
[TBL] [Abstract][Full Text] [Related]
13. Acute biphenotypic leukaemia (myeloid and null-ALL type) supervening in a myelodysplastic syndrome.
Eridani S; Chan LC; Halil O; Pearson TC
Br J Haematol; 1985 Nov; 61(3):525-9. PubMed ID: 3864486
[TBL] [Abstract][Full Text] [Related]
14. Novel in situ double labeling for simultaneous detection of proliferation and apoptosis.
Mundle S; Iftikhar A; Shetty V; Dameron S; Wright-Quinones V; Marcus B; Loew J; Gregory S; Raza A
J Histochem Cytochem; 1994 Dec; 42(12):1533-7. PubMed ID: 7983354
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro growth characteristics of blast cell progenitors (CFU-L) in patients with myelodysplastic syndromes and acute myeloid leukemia.
Aul C; Gattermann N; Schneider W
Blood; 1992 Aug; 80(3):625-33. PubMed ID: 1638020
[TBL] [Abstract][Full Text] [Related]
16. Prognostic importance of hypodiploid hemopoietic precursors in myelodysplastic syndromes.
Clark R; Peters S; Hoy T; Smith S; Whittaker K; Jacobs A
N Engl J Med; 1986 Jun; 314(23):1472-5. PubMed ID: 3702962
[TBL] [Abstract][Full Text] [Related]
17. In situ localization of transforming growth factor beta and S-phase cells in patients with acute myeloid leukemia and myelodysplastic syndrome.
Qadir K; Bokhari SA; Miller MA; Siegrist C; Bismayer J; Raza A
Anticancer Res; 1992; 12(2):403-7. PubMed ID: 1580558
[TBL] [Abstract][Full Text] [Related]
18. A guide to risk assessment in the primary myelodysplastic syndrome.
Mufti GJ
Hematol Oncol Clin North Am; 1992 Jun; 6(3):587-606. PubMed ID: 1613008
[TBL] [Abstract][Full Text] [Related]
19. Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia.
Rosenthal NS; Farhi DC
Am J Clin Pathol; 1991 Apr; 95(4):556-60. PubMed ID: 2014782
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication and characterization of the blast cell population in the myelodysplastic syndrome.
Goasguen JE; Bennett JM; Cox C; Hambley H; Mufti G; Flandrin G
Leuk Res; 1991; 15(12):1159-65. PubMed ID: 1766264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
